Peregrine Pharmaceuticals reported $63.25M in Current Liabilities for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acceleron Pharma XLRN:US $ 57.37M 2.11M
Adamas Pharmaceuticals ADMS:US 23.84M 2.02M
Amgen AMGN:US $ 14842M 257M
AstraZeneca AZN:LN 23649M 1427M
Bristol Myers Squibb BMY:US $ 21460M 2469M
Celldex Therapeutics CLDX:US $ 14.18M 0.31M
Chemocentryx CCXI:US $ 60.03M 4.65M
Dicerna Pharmaceuticals DRNA:US $ 239.3M 31.64M
Eli Lilly And LLY:US $ 13682M 1411.2M
Flexion Therapeutics FLXN:US $ 43.99M 4.06M
GlaxoSmithKline GSK:LN 22417M 1030M
Immunogen IMGN:US $ 111.78M 8.53M
Intrexon XON:US $ 28.99M 0.12M
Karyopharm Therapeutics KPTI:US $ 68.87M 10.74M
Kindred Biosciences KIN:US $ 11.26M 4.71M
Macrogenics MGNX:US $ 68.86M 1.06M
Mannkind MNKD:US $ 50.03M 10.4M
Minerva Neurosciences NERV:US $ 3.08M 1.36M
Newlink Genetics NLNK:US $ 6.05M 0.72M
Novartis NOVN:VX SF 29880M 247M
Novavax NVAX:US $ 1753.42M 101.9M
Peregrine Pharmaceuticals PPHM:US $ 63.25M 7.69M
Repligen RGEN:US $ 349.44M 17.1M
Xencor XNCR:US $ 44.32M 1.64M